Aequo has successfully represented Darnitsa, a leading Ukrainian pharmaceutical company, in a patent dispute against Zdorovye, another major Ukrainian pharma manufacturer.
The matter was considered by commercial courts and finally resolved by the Supreme Court ruling in favour of Darnitsa and confirming a key Zdorovye patent invalid.
Darnitsa initiated the proceedings back in 2015, claiming that Zdorovye patent for invention protecting use of certain pharmaceutical composition lacked novelty. The case was complicated by hotly debated issues on numerous expert reports, which addressed the patentability criteria of the disputed patent. Among others, the scope of work also included advice on various provisions of Ukrainian patent law, procedural law and drafting relevant documents.